Zengjun Fang

No. 247 Beiyuan Avenue
Jinan, 250033, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

pH-triggered "PEG" sheddable and folic acid-targeted nanoparticles for docetaxel delivery in breast cancer treatment.

pH-triggered "PEG" sheddable and folic acid-targeted nanoparticles for docetaxel delivery in breast cancer treatment.

Journal: International journal of pharmaceutics

Published: April 10, 2023

Ginsenoside Rb2: A review of pharmacokinetics and pharmacological effects.

Ginsenoside Rb2: A review of pharmacokinetics and pharmacological effects.

Journal: Journal of ginseng research

Published: March 23, 2021

Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein.

Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein.

Journal: PloS one

Published: October 26, 2020

Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties.

Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties.

Journal: Journal of medicinal chemistry

Published: April 16, 2020

Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel.

Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel.

Journal: Journal of medicinal chemistry

Published: January 15, 2020

Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy.

Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy.

Journal: International journal of pharmaceutics

Published: August 15, 2019

Discovery of novel anti-influenza agents via contemporary medicinal chemistry strategies (2014-2018 update).

Discovery of novel anti-influenza agents via contemporary medicinal chemistry strategies (2014-2018 update).

Journal: Future medicinal chemistry

Published: March 20, 2019

Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.

Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.

Journal: Journal of medicinal chemistry

Published: October 27, 2018

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.

Journal: Journal of medicinal chemistry

Published: July 03, 2018

Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.

Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.

Journal: Journal of medicinal chemistry

Published: May 09, 2017

Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.

Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.

Journal: Journal of medicinal chemistry

Published: August 20, 2016

A recombinant plasmid of composite cysteine proteinase inhibitor/glyceraldehyde-3-phosphate dehydrogenase gene of periodic Brugia malayi functions on DNA immunity in the host.

A recombinant plasmid of composite cysteine proteinase inhibitor/glyceraldehyde-3-phosphate dehydrogenase gene of periodic Brugia malayi functions on DNA immunity in the host.

Journal: Indian journal of medical microbiology

Published: April 16, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026